The U.S. Food and Drug Administration (FDA) will host a workshop on drug development and CFS and ME on April 25-26, 2013. This FDA workshop will... Read More
From the blog
Putting the Patient at the Center: FDA’s New Series Premiers with ME/CFS
It’s rare that ME/CFS as a disease category experiences a “first” that’s positive. Here’s one worth celebrating: the March 11, 2013... Read More
CFS Advisory Committee Meets May 22-23
The federal Chronic Fatigue Syndrome Advisory Committee (CFSAC) meets next on May 22-23, 2013 in Washington, D.C. This chartered advisory committee... Read More
CFIDS Association Announces Leadership Transition
The CFIDS Association of America announces that longtime president and CEO, K. Kimberly McCleary, will be leaving her role as the organization’s... Read More
You’re At the Center: Learn How the CFIDS Association is Fostering Developing of Safe and Effective Treatments for ME/CFS
The fourth webinar in our spring series focuses on how the CFIDS Association is fostering the development of safe and effective therapies for ME/CFS.... Read More
Find Out How FDA Defines “Safe and Effective”: April 11 Webinar
View the third webinar in spring series: http://bit.ly/apr-11-webinar, recorded on April 11. In just about two weeks, the U.S. Food and Drug Administration... Read More
Upcoming Webinar: Finding Your Strongest Voice for Public Testimony
The upcoming FDA Workshop on Drug Development is a historic opportunity for the ME/CFS* community to establish ME/CFS as a priority for drug development.... Read More


